Treatment of Bleeding in Patients with Platelet Disorders: Is There a Place for Recombinant Factor VIIa?

Publisher： Karger

E-ISSN： 1424-8840|32|1|37-40

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.1, 2002-05, pp. : 37-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

More on: platelet count and the Use of Recombinant Factor VIIa for the treatment of Bleeding Complications after Hematopoietic Stem Cell Transplantation

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 288-288

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant Factor VIIa Reduces Bleeding Risk in Patients on Platelet Aggregation Inhibitors Immediately prior to Renal Transplantation – A Retrospective Analysis

By  

Urologia Internationalis, Vol. 78, Iss. 2, 2007-02 ,pp. : 135-139

Karger

Access to resources Recommend Favorite

Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation

By Gielen-Wijffels S.   Mook W.   Geest S.   Ramsay G.  

Intensive Care Medicine, Vol. 30, Iss. 6, 2004-06 ,pp. : 1232-1234

Springer Publishing Company

Access to resources Recommend Favorite

The Use of Recombinant Factor VIIa in Controlling Surgical Bleeding in Non-Haemophiliac Patients

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 41-46

Karger

Access to resources Recommend Favorite

Treatment of Acute Bleeding with Recombinant Factor VIIa in a Patient with IgA Deficit Receiving Anticoagulant Therapy

By  

Acta Haematologica, Vol. 110, Iss. 1, 2003-09 ,pp. : 51-52

Karger

Access to resources Recommend Favorite